NEW YORK, July 26 /PRNewswire/ -- The American Stock Exchange(R) (Amex(R)) today listed the common stock of ULURU, Inc. under the ticker symbol ULU.
The Company is a diversified pharmaceutical company engaged in the development of novel topically applied therapeutics based primarily on the adaptation of existing therapeutic agents using its proprietary drug delivery platforms to improve clinical outcomes.
"We are pleased to welcome ULURU, Inc.," said John McGonegal, Senior Vice President of Amex's Equities Group. "ULURU joins a growing roster of pharmaceutical companies that have chosen to list at the Amex and we look forward to providing them with the solid support and services that are essential in today's competitive marketplace."
Kerry P. Gray, President and CEO of ULURU Inc., stated, "We are delighted to have been accepted to trade on the Amex and believe that the increased visibility that this will bring to the company will be of great assistance in helping us achieve our objective of maximizing shareholder value".
The specialist in ULURU, Inc. will be HBH Specialists LLC. For further information on ULU and other Amex-listed companies, please visit www.amex.com.
About American Stock Exchange
The American Stock Exchange(R) (Amex(R)) offers trading across a full range of equities, options and exchange traded funds (ETFs), including structured products and HOLDRS(SM). In addition to its role as a national equities market, the Amex is the pioneer of the ETF, responsible for bringing the first domestic product to market in 1993. Leading the industry in ETF listings, the Amex lists 336 ETFs to date. The Amex is also one of the largest options exchanges in the U.S., trading options on broad-based and sector indexes as well as domestic and foreign stocks. For more information, please visit www.amex.com
American Stock ExchangeCONTACT: Catherine Chantharaj of American Stock Exchange, +1-212-306-1689,catherine.chantharaj@amex.com
Web site: http://www.amex.com/
